Alexis Borisy has $200M to back a market-based plan aimed at curing America’s drug pricing ‘sickness’

SAN FRANCISCO — As a high-profile figure in the biotech boom that has transformed the industry over the last decade, Alexis Borisy co-founded a slew of startups. One of those companies is Blueprint Medicines, where he has been on the board since 2011. A few days ago, Borisy’s biotech reached…

Click to view original post